BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2024 9:51:56 AM | Browse: 398 | Download: 889
Publication Name World Journal of Clinical Oncology
Manuscript ID 91092
Country Poland
Received
2023-12-21 13:11
Peer-Review Started
2023-12-21 13:11
First Decision by Editorial Office Director
2024-01-30 02:28
Return for Revision
2024-01-30 09:42
Revised
2024-02-03 12:14
Publication Fee Transferred
Editorial Processing by Scientific Editor
2024-03-22 02:43
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2024-03-22 06:29
Articles in Press
2024-03-22 06:29
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-04-10 01:44
Publish the Manuscript Online
2024-04-22 09:51
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Britanin – a beacon of hope against gastrointestinal tumors?
Manuscript Source Invited Manuscript
All Author List Agnieszka Kajdanek, Damian Kołat, Lin-Yong Zhao, Mateusz Kciuk, Zbigniew Pasieka and Żaneta Kałuzińska-Kołat
ORCID
Author(s) ORCID Number
Agnieszka Kajdanek http://orcid.org/0009-0006-7265-331X
Damian Kołat http://orcid.org/0000-0002-1086-3796
Lin-Yong Zhao http://orcid.org/0000-0003-0884-4657
Mateusz Kciuk http://orcid.org/0000-0002-8616-3825
Zbigniew Pasieka http://orcid.org/0000-0001-8931-0213
Żaneta Kałuzińska-Kołat http://orcid.org/0000-0002-2335-3293
Funding Agency and Grant Number
Corresponding Author Żaneta Kałuzińska-Kołat, BSc, MSc, Research Assistant, Teaching Assistant, Department of Biomedicine and Experimental Surgery, Medical University of Lodz, Narutowicza 60, Lodz 90-136, Lodzkie, Poland. zaneta.kaluzinska@umed.lodz.pl
Key Words Britanin; Sesquiterpene lactones; Chemotherapeutics; Gastrointestinal tumors; In vitro; In vivo
Core Tip Natural compounds have settled in the development of novel drugs. Britanin is a sesquiterpene lactone whose effect on gastrointestinal tumors has not been summarized before. Our paper reviews the current state of knowledge and proposes novel research directions. Britanin was found to counteract liver, colorectal, pancreatic, and gastric tumors via the regulation of proliferation, apoptosis, autophagy, immune response, migration, and angiogenesis. Future research should examine the link between Britanin and acetylcholinesterase, mast cells, osteolysis, and ischemia. The compound holds promise as an anti-cancer agent and may overcome the paucity of treatment options or high mortality rate in gastrointestinal tumors.
Publish Date 2024-04-22 09:51
Citation Kajdanek A, Kołat D, Zhao LY, Kciuk M, Pasieka Z, Kałuzińska-Kołat Ż. Britanin – a beacon of hope against gastrointestinal tumors? World J Clin Oncol 2024; 15(4): 523-530
URL https://www.wjgnet.com/2218-4333/full/v15/i4/523.htm
DOI https://dx.doi.org/10.5306/wjco.v15.i4.523
Full Article (PDF) WJCO-15-523-with-cover.pdf